Skip to main content
Print Page    E-mail Page    RSS    E-mail Alerts    Tearsheet 

Investors & Media

Corporate Profile

Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing a novel class of biological drugs, which we refer to as Ecobiotic microbiome therapeutics, that are designed to restore health by repairing the function of a dysbiotic microbiome. The Company’s lead product candidate, SER-109, is intended to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon, and, if approved by the FDA, could be a first-in-field drug. Using its... More

Recent NewsMore
Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress
Seres Therapeutics to Present at the Canaccord Genuity 37th Annual Growth Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 2, 2017-- Seres Therapeutics, Inc. (NASDAQ:MCRB) today announced it will present at the Canaccord Genuity 37th Annual Growth Conference in Boston, MA on Wednesday, August 9 at 1:00 p.m. ET. A live audio webcast of the presentation will be available under the “Investors and Media” section of Seres’ website. A replay of the presentation will become available approximately one hour after the even... 
Seres Therapeutics to Host Second Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on August 3, 2017
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 27, 2017-- Seres Therapeutics, Inc. (NASDAQ:MCRB) today announced that management will host a conference call and live audio webcast on August 3, 2017 at 8:00 a.m. ET to discuss second quarter 2017 results and provide a general business update. To access the conference call, please dial 844-277-9450 (domestic) or 336-525-7139 (international) and reference the conference ID number 62118608. To join th... 
There are currently no upcoming events scheduled.
Stock Quote
 - 0.39 (2.93%)
08/18/17 4:00 p.m. ET
Refresh quote
E-mail Alerts
Sign up to receive e-mail alerts whenever Seres Therapeutics, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
Request Information

Obtain investor relations information by contacting us.

Data provided by Nasdaq. Minimum 15 minutes delayed.